A biomarker panel composed of four proteins (S100P, pVHL, MUC5AC and KRT17) was reported to be helpful in discriminating between primary ICC and metastatic PDAC by Lok et al. [20]. The gene discussed is S100P; the disease is intrahepatic cholangiocarcinoma.